Abstract

BackgroundSuppressor of cytokine signaling 3 (SOCS3) is an inducible endogenous negative regulator of signal transduction and activator of transcription 3 (STAT3). Epigenetic silencing of SOCS3 has been shown in head and neck squamous cell carcinoma (HNSCC), which is associated with increased activation of STAT3. There is scarce information on the functional role of the reduction of SOCS3 expression and no information on altered subcellular localization of SOCS3 in HNSCC.Methodology/Principal FindingsWe assessed endogenous SOCS3 expression in different HNSCC cell lines by RT-qPCR and western blot. Immunofluorescence and western blot were used to study the subcellular localization of endogenous SOCS3 induced by IL-6. Overexpression of SOCS3 by CMV-driven plasmids and siRNA-mediated inhibition of endogenous SOCS3 were used to verify the role of SOCS3 on tumor cell proliferation, viability, invasion and migration in vitro. In vivo relevance of SOCS3 expression in HNSCC was studied by quantitative immunohistochemistry of commercially-available tissue microarrays. Endogenous expression of SOCS3 was heterogeneous in four HNSCC cell lines and surprisingly preserved in most of these cell lines. Subcellular localization of endogenous SOCS3 in the HNSCC cell lines was predominantly nuclear as opposed to cytoplasmic in non-neoplasic epithelial cells. Overexpression of SOCS3 produced a relative increase of the protein in the cytoplasmic compartment and significantly inhibited proliferation, migration and invasion, whereas inhibition of endogenous nuclear SOCS3 did not affect these events. Analysis of tissue microarrays indicated that loss of SOCS3 is an early event in HNSCC and was correlated with tumor size and histological grade of dysplasia, but a considerable proportion of cases presented detectable expression of SOCS3.ConclusionOur data support a role for SOCS3 as a tumor suppressor gene in HNSCC with relevance on proliferation and invasion processes and suggests that abnormal subcellular localization impairs SOCS3 function in HNSCC cells.

Highlights

  • The SOCS family of structurally related proteins is mainly characterized as endogenous negative regulators of JAK-STAT signaling

  • Epigenetic silencing of Suppressor of cytokine signaling 3 (SOCS3) has been reported in head and neck squamous cell carcinoma (HNSCC) [7], suggesting that decreased expression of SOCS3 could represent an important cause of constitutive JAK/STAT activation in HNSCC and supporting the notion that SOCS3 could function as a tumor suppressor gene

  • In two cell lines (OSCC3 and UM-SCC-11B) significant induction of SOCS3 mRNA was observed in response to IL-6 stimulation, which was observed in the non-neoplastic cell line (HaCAT) indicating the responsiveness of JAK-STAT signaling

Read more

Summary

Introduction

The SOCS family of structurally related proteins is mainly characterized as endogenous negative regulators of JAK-STAT signaling. Epigenetic silencing of SOCS3 has been reported in head and neck squamous cell carcinoma (HNSCC) [7], suggesting that decreased expression of SOCS3 could represent an important cause of constitutive JAK/STAT activation in HNSCC and supporting the notion that SOCS3 could function as a tumor suppressor gene. This notion is further supported by the finding that restoring SOCS3 expression in tumor cell lines results in growth suppression and induction of apoptosis [7]. There is scarce information on the functional role of the reduction of SOCS3 expression and no information on altered subcellular localization of SOCS3 in HNSCC

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call